Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12775735

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2003 Jun 1
First author
Mouridsen H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Aug 1;22(15):3199-200; author reply 3200-1. doi: 10.1200/JCO.2004.99.058.
    note
    Source null
    related pmid
    15284276
    relationship
    Comment in

Authors and identifiers

  1. name
    Mouridsen H
    type
    Author
  2. name
    Gershanovich M
    type
    Author
  3. name
    Sun Y
    type
    Author
  4. name
    Perez-Carrion R
    type
    Author
  5. name
    Boni C
    type
    Author
  6. name
    Monnier A
    type
    Author
  7. name
    Apffelstaedt J
    type
    Author
  8. name
    Smith R
    type
    Author
  9. name
    Sleeboom HP
    type
    Author
  10. name
    Jaenicke F
    type
    Author
  11. name
    Pluzanska A
    type
    Author
  12. name
    Dank M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mouridsen H
    type
    Author
  2. name
    Gershanovich M
    type
    Author
  3. name
    Sun Y
    type
    Author
  4. name
    Perez-Carrion R
    type
    Author
  5. name
    Boni C
    type
    Author
  6. name
    Monnier A
    type
    Author
  7. name
    Apffelstaedt J
    type
    Author
  8. name
    Smith R
    type
    Author
  9. name
    Sleeboom HP
    type
    Author
  10. name
    Jaenicke F
    type
    Author
  11. name
    Pluzanska A
    type
    Author
  12. name
    Dank M
    type
    Author
bibliography ids
  1. nci-bib-9c01f50e6d035ab135c9751c
book metadata
content sha256
dfca81524c53e87e34ebc92eda3e7b5662dcfe9ffb10837bdbe391d3e2bf1b6c
document type
citation
dois
  1. 10.1200/JCO.2003.04.194
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12775735
immutable id
pubmed:12775735@dfca81524c53e87e34ebc92eda3e7b5662dcfe9ffb10837bdbe391d3e2bf1b6c
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2101-9
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Aug 1;22(15):3199-200; author reply 3200-1. doi: 10.1200/JCO.2004.99.058.
    note
    Source null
    related pmid
    15284276
    relationship
    Comment in
outcomes validated
false
pmid
12775735
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
55ef6be6b51d355c98752ff850c9b265c00749d2d1e62f294ed9f27785c04567
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Jun 1
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12775735/
title
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.

Preserved source evidence · Not medical advice